Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Vaccine Effectiveness × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 56 Prostatic Neoplasms 23 Neoplasms 21 Multiple Myeloma 18 Carcinoma, Hepatocellular 15 Stomach Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Colorectal Neoplasms 11 Papillomavirus Infections 9 Lung Neoplasms 9 Pain, Postoperative 8 Waldenstrom Macroglobulinemia 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Melanoma 7 Polycystic Ovary Syndrome 6 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Lymphoma, Non-Hodgkin 6 Leukemia, Myeloid, Acute 6 Leiomyoma 6 Brain Neoplasms 6 Venous Thromboembolism 5 Smoking Cessation 5 Sarcoma 5 Recurrence 5 Lymphoma 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Kidney Neoplasms 5 Hematologic Neoplasms 5 Glioma 5

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡